Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/05/066920
CTRI/2024/05/066920
Not yet recruiting
未知

Improving exclusive breastfeeding through effective interventional counselling in an immunisation clinic in a tertiary hospital - NI

Kasturba Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kasturba Hospital
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • •The study groups consist of clinically stable mother\-infant pair seen at the
  • •immunization clinic at 6\-8 weeks of age

Exclusion Criteria

  • •Infants who were born preterm
  • •Congenital anomalies
  • •Chromosomal anomalies
  • •Surgical conditions, if any
  • •Not given consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Whole Foods versus Supplements to Reduce Oxidative Stress in the AirwaysAsthmaRespiratory - Asthma
ACTRN12605000125628Hunter New England Area Health Service20
Recruiting
Phase 1
An adaptive, randomized, placebo-controlled, double-blind study to evaluate the safety and efficacy of RL-007 in the treatment of cognitive impairment associated with schizophrenia (CIAS)
CTIS2023-506570-12-01Recognify Life Sciences Inc.234
Completed
Not Applicable
A first-in-human, single-centre, placebo-controlled, randomized, double-blind study in healthy subjects to evaluate safety, tolerability, pharmacokinetics and food effect after oral single and multiple ascending dosing of KAND567MSMultiple sclerosis10012303
NL-OMON44294Kancera AB98
Active, not recruiting
Not Applicable
A clinical trial to assess the efficacy of Selenium in Morbus Basedow
EUCTR2010-022840-19-DEniversitätsmedizin Mainz
Active, not recruiting
Not Applicable
A randomised, open-label, placebo-controlled, single centre study in healthy male volunteers to explore efficacy, safety and tolerability of single doses of low molecular weight dextran sulfate (LMW-DS) in combination with recombinant human granulocyte colony stimulating factor (rhG-CSF, filgrastim) and in comparison with plerixafor treatment and placebo
EUCTR2014-000659-10-SETikoMed AB